Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NANOFACTURING

Financiado

Cerrado

The Development of Medium and Large Scale Sustainable Manufacturing Process Pla...

The Development of Medium and Large Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals A number of nanomedicine formulations have enabled, or been shown to hold considerable potential for enabling more effective and less toxic therapeutic interventions. However, progress to date in translating these initiatives to... ver más

31/01/2019

MIDATECH PHARMA ES...

9M€

Presupuesto del proyecto: 9M€

Líder del proyecto

MIDATECH PHARMA ESPAÑA La investigacion y desarrollo de nanoparticulas, en cualquier campo

TRL 3-4 | 109K€

Fecha límite participación Sin fecha límite de participación.

Ver 11 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-01-31

NMP-08-2014: Scale-up of nanopharmaceuticals pro...

I+D

Cerrada hace 10 años

0% 90% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

11 Participantes

MIDATECH PHARMA ESPAÑA

2.52M€ | Lider

GEDESCO

179.70K€ | Participante

76.62K€ | Participante

NUID UCD

612.92K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NANOMED Nanomedicine an integrative approach 4M€ Cerrado

PID2019-104334RB-I00 CARACTERIZACION, SEGUIMIENTO Y ESTUDIO DEL IMPACTO BIOLOGICO... 145K€ Cerrado

RYC2021-034576-I Multifunctional nanomaterials for the design of novel immuno... 236K€ Cerrado

NOBEL Mobilising the European nano biomedical ecosystem 2M€ Cerrado

RYC-2015-17640 Bioorganic chemistry and multifunctional nanomaterials for b... 309K€ Cerrado

IJC2020-043746-I Desarrollo de nanosistemas biomiméticos y multifuncionales p... 31K€ Cerrado

Duración del proyecto: 49 meses Fecha Inicio: 2014-12-15
Fecha Fin: 2019-01-31

Líder del proyecto

MIDATECH PHARMA ESPAÑA La investigacion y desarrollo de nanoparticulas, en cualquier campo

TRL 3-4 | 109K€

Presupuesto del proyecto 9M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto A number of nanomedicine formulations have enabled, or been shown to hold considerable potential for enabling more effective and less toxic therapeutic interventions. However, progress to date in translating these initiatives to commercial success has been limited. One of the main reasons for this bottleneck is due to the inability of researchers and stakeholders to manufacture batches of the nanomedicine product at the required scale and according to Good Manufacturing Practice (GMP) requirements. The NANOFACTURING project will focus on - facilitating access to required infrastructures and expertise - creating GMP pilot lines for up-scaling manufacturing - addressing the current developmental and production gaps - taking nanomaterials already successfully produced at proof-of-concept/milligram levels and facilitating their scale-up to sub-kilogram quantities - providing large-scale and GMP production for clinical trials and nanomedicine translation. The NANOFACTURING project, through a consortium of 9 partners, will develop the synthetic processes, process control methods, analytical assays for QA/QC, functional specifications, and best practices, interfacing existing R&D centres of excellence, transfer organisations and private GMP manufacturing facilities (including SMEs) to ensure efficient translation from discovery through to first in man, proof-of-concept studies and beyond to Phase III according to industrial and regulatory standards. Specifically, the NANOFACTURING project aims to create a platform process for early, mid- and large-scale manufacturing of glycan-coated gold nanoparticles (GNPs), a widely researched and developed class of self-forming nanoparticles. The ability to engineer new nanopharmaceuticals based on this patent protected platform technology, developed by Midatech Biogune S.L. (Project Coordinator), will have inherent advantages over existing treatments for multiple therapeutic areas.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores